Table 7 Comparison of the quantification of laboratory tests for ANA-positive RR-positive, ANA-positive RR-negative, and ANA-negative patients
From: High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection
Marker | RR-positive | RR-negative | ANA-negative | p-value |
|---|---|---|---|---|
AST (U/L) | 101.23 ± 92.51 | 71.04 ± 44.87 | 65.85 ± 37.88 | 0.3779k |
ALT (U/L) | 106.6 ± 84.04 | 55.95 ± 28.63 | 77.59 ± 54.47 | 0.2301k |
GGT (U/L) | 110.43 ± 86.45 | 97.72 ± 82.19 | 95.1 ± 19.95 | 0.6711k |
ALP (U/L) | 121.65 ± 44.14 | 122.4 ± 64.38 | 119.13 ± 56.18 | 0.9841A |
TB (mg/dL) | 0.92 ± 0.63 | 1.8 ± 2.19 | 0.86 ± 0.47 | 0.6678k |
DB (mg/dL) | 0.36 ± 0.36 | 0.49 ± 0.54 | 0.27 ± 0.17 | 0.9792k |
IB (mg/dL) | 0.61 ± 0.31 | 1.32 ± 1.86 | 0.59 ± 0.38 | 0.5923k |
TP (g/dL) | 7.22 ± 0.55 | 7.63 ± 0.86 | 7.59 ± 1.03 | 0.6204A |
Albumin (g/dL) | 3.97 ± 0.53 | 4.27 ± 0.55 | 4.23 ± 0.65 | 0.3685k |
Globulin (g/dL) | 3.37 ± 0.87 | 3.35 ± 0.65 | 3.36 ± 1.04 | 0.9787k |
PT (%) | 84.74 ± 15.91 | 74.75 ± 18.93 | 83.32 ± 20.51 | 0.5493A |
Platelets (× 103) | 157.8 ± 54.4 | 196.7 ± 104.86 | 205.75 ± 76.9 | 0.2211k |
VL (log10) | 5.64 ± 0.39 | 5.51 ± 0.27 | 5.49 ± 0.84 | 0.8064k |